Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial. [electronic resource]
Producer: 20190130Description: 1035-1043 p. digitalISSN:- 2055-5822
- Aged
- Body Weight
- Double-Blind Method
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Heart Failure -- complications
- Humans
- Hypoglycemic Agents -- administration & dosage
- Injections, Subcutaneous
- Liraglutide -- administration & dosage
- Male
- Middle Aged
- Obesity -- complications
- Stroke Volume -- physiology
- Treatment Outcome
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.